Westwood Holdings Group’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $293K | Hold |
26,097
| – | – | ﹤0.01% | 421 |
|
|
2025
Q1 | $119K | Hold |
26,097
| – | – | ﹤0.01% | 459 |
|
|
2024
Q4 | $147K | Hold |
26,097
| – | – | ﹤0.01% | 481 |
|
|
2024
Q3 | $126K | Hold |
26,097
| – | – | ﹤0.01% | 467 |
|
|
2024
Q2 | $127K | Hold |
26,097
| – | – | ﹤0.01% | 449 |
|
|
2024
Q1 | $347K | Hold |
26,097
| – | – | ﹤0.01% | 418 |
|
|
2023
Q4 | $364K | Hold |
26,097
| – | – | ﹤0.01% | 410 |
|
|
2023
Q3 | $346K | Sell |
26,097
-7,254
| -22% | -$96.2K | ﹤0.01% | 403 |
|
|
2023
Q2 | $625K | Sell |
33,351
-525
| -2% | -$9.84K | 0.01% | 374 |
|
|
2023
Q1 | $488K | Buy |
33,876
+7,779
| +30% | +$112K | ﹤0.01% | 396 |
|
|
2022
Q4 | $505K | Hold |
26,097
| – | – | ﹤0.01% | 400 |
|
|
2022
Q3 | $896K | Hold |
26,097
| – | – | 0.01% | 326 |
|
|
2022
Q2 | $399K | Buy |
26,097
+17,024
| +188% | +$260K | ﹤0.01% | 404 |
|
|
2022
Q1 | $207K | Buy |
+9,073
| New | +$207K | ﹤0.01% | 446 |
|